TEAR Victoria Jane,ROBERTS James Jonathan Welch,MONK Phillip David
申请号：
SI201130956
公开号：
SI2544705T1
申请日:
2011.03.10
申请国别(地区):
SI
年份:
2016
代理人:
摘要：
An agent selected from: (a) interferon-β (IFN-β)； (b) an agent that increases IFN-β expression； or (c) a polynucleotide which is capable of expressing (a) or (b)； for use in the treatment of individuals with lower respiratory tract illness that has developed during or following an established ILI, wherein said treatment is by airway delivery of said medicament.
